What data is there to support duration of ADT following EBRT for presumably localized residual cancer following RARP. I am now 2 months into Orgovyx awaiting the start of EBRT for a single spot shown on Pylarify on the right pelvic sidewall (node?). Surgical specimin showed no extension of cancer except into both seminal vesicles (P3b). Despite Gleason 9 pathology, I had hoped for a clean cure. No such luck when post op PSA was .123 and then .2 two months later. Thanks to the advice from this board and a study that was posted, I decided to wait 6 months post surgery to begin Salvage EBRT in order to allow my incontinence to improve - which it did. That study suggested maximum improvement at 6-7 months. I started Orgovyx to buy some time. First month - no problem. Second month is when the night sweats and sleep disturbance kicked it big time. I gained 8 pounds despite diet, going to the gym and running daily. No fatigue or mood changes. I chose the pills (despite the cost) because I wanted to be able to quickly stop ADT when I could. It did not make sense to me that when the SRT was completed and presumably killed off the cancer, that I would need further ADT. I planned to take 6 months of ADT, 2 months before, 2 months during and 2 months following EBRT - then follow PSA off therapy to determine if treatment plan was successful. I meet with radiation oncologist in 2 weeks for my planning session. Is my thinking erroneous? Is there any data for duration of ADT post EBRT in this situation? I am 71, happy to be alive but more happy if I could get rid of ADT.
Post Edited (Dr.V) : 1/17/2022 6:25:20 AM (GMT-7)